key: cord-0793424-fzyndklq
authors: Mayor‐Ibarguren, A; Feito‐Rodriguez, M; Quintana Castanedo, L; Ruiz‐Bravo, E; Montero Vega, D; Herranz‐Pinto, P
title: Cutaneous small vessel vasculitis secondary to COVID‐19 infection: A case report
date: 2020-05-22
journal: J Eur Acad Dermatol Venereol
DOI: 10.1111/jdv.16670
sha: 9afe0ea918a4e2dd21bbdee5f76c90139dc13428
doc_id: 793424
cord_uid: fzyndklq

We present a case of an 83‐year‐old woman with a history of hypertension, transient ischemic attack (TIA), atrial fibrillation, chronic renal impairment presented to our dermatology emergency room on April 9, 2020, for evaluation of purple palpable papules and serohaematic blisters on both her lower legs, feet and toes that had appeared 5 days earlier (Figure 1).

This article is protected by copyright. All rights reserved Dear editor, We present a case of an 83-year-old woman with a history of hypertension, transient ischemic attack (TIA), atrial fibrillation, chronic renal impairment presented to our dermatology emergency room on April 9, 2020, for evaluation of purple palpable papules and serohaematic blisters on both her lower legs, feet and toes that had appeared 5 days earlier ( Figure 1 ). She denied having any new medications, and she had been undergoing long-term treatment with acenocoumarol and furosemide for her prior conditions. A month before the cutaneous lesions developed, she had a history of one week of sore throat, followed by malaise and nausea. She did not present dyspnoea, chest pain, diarrhoea, smell or taste alterations, nor fever. A clinical

This article is protected by copyright. All rights reserved diagnosis of cutaneous vasculitis was made. We performed a 4-mm punch biopsy of one palpable purple papule. A complete blood test and urinalysis were performed. The patient was started on 30 mg/day prednisone therapy with clinical improvement achieved after 10 days, after which the medication was progressively tapered. Laboratory testing showed a normal white blood cell count. Thrombocytopaenia was not observed. C-reactive-protein was 8.0 mg/L (normal value 0.0 -5.9) and serum lactate dehydrogenase was 279 UI/L (normal value 100-190). Hepatic function was not impaired. Creatinine was 1.44 mg/dl (normal value 0.50-1.10), and this finding was related to prior chronic renal disease. Urinalysis showed no signs of proteinuria nor haematuria.

Serum IgG, IgM and IgA levels were within normal ranges. Immunological lab results showed negative values for anti-nuclear antibodies and anti-neutrophil cytoplasmic antibodies (ANCAs).

IgM cardiolipin antibodies were slightly increased: 21.29 (MPL) (normal value <20.00).

Complement C3 and C4 levels were not decreased. Serum cryoglobulins were negative. CSVV represents a subgroup of vasculitis limited to the skin, usually attributed to drugs or infections (6) . Deposition of immune complexes which activate the complement cascade, are thought to be the main pathogenic factor that causes small vessel wall damage in LCV (7).

Interleukin (IL)-6 levels have also been shown to be increased in hypersensitivity and other vasculitis conditions (8) . IL-6 elevation has been associated with the large cytokine storm that results in severe COVID-19 infection (9) . Thus, we postulated that the CSVV in our patient might

This article is protected by copyright. All rights reserved have been due to an immune response against viral antigen deposition or as a result of IL-6 elevation during infection, which might have produced endothelial damage. The slightly increased anticardiolipin IgM antibodies could be related to acute infection (10). We did not find any other symptoms or signs suggesting any systemic involvement due to vasculitis. Similarly, we did not suspect any thrombotic event, other than the fact that the patient was already undergoing anticoagulant therapy

We present a case of CSVV or LCV attributable to COVID-19, as shown by convalescent phase positive IgM and IgG antibodies. We conclude that cutaneous vasculitis should be considered as a possible consequence of SARS-COV-2 infection during this pandemic. 

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Urticarial eruption in COVID-19 infection

Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients

Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients

revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

Cutaneous manifestations in COVID-19: a first perspective

Accepted Article This article is protected by copyright. All rights reserved

7-Carlson JA. The histological assessment of cutaneous vasculitis

Hypersensitivity vasculitis and cytokines

Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients